Is a complete TRDA research report available?

No complete published report is available for Entrada Therapeutics, Inc. (TRDA) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Entrada Therapeutics, Inc. (TRDA)

NASDAQ: TRDA · USD

$6.77

+0.22 (+3.4%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first TRDA analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	243.9M
Revenue (ttm)	5.7M
Net income (ttm)	-166.1M
EPS (ttm)	-$4.00
Shares out	36M
Volume	594,731
Beta	-0.26
Price target	$18.8	+177.0%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 5.7M
Net income (ttm): -166.1M
EPS (ttm): -$4.00
Market cap: 243.9M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All TRDA indicators

Market & fundamental data

Available fields

206

Groups with data

Currency

USD

Showing 206 of 206 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001689375
Company name	Entrada Therapeutics, Inc.
Country	United States
Country code	US
Cusip	29384C108
Employees	152
Employees Change	-31%
Employees Change Percent	-16.94
Enterprise value	$38.8M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2021-10-29
Isin	US29384C1080
Last refreshed	2026-07-31
Market cap	$243.9M
Market cap category	Micro-Cap
Price	$6.77
Price currency	USD
Rev Per Employee	37,750x
Sector	Healthcare
Sector PE	45.56
Sector PE Fwd	24.38
Sic	2834
Symbol	TRDA
Website	https://www.entradatx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-68.1%
EV Sales Forward	1.05x
EV/Sales	6.77x
FCF yield	-53.96%
P/B ratio	0.87x
P/S ratio	42.51x
PS Forward	6.57x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-3,109.29%
EBITDA Margin	-3,040.36%
Gross Profit	$-135.8M
Net Income	$-166.1M
Net Income Growth Years	0%
Pretax Margin	-2,878.29%
Profit Per Employee	$-1.1M
ROA	-26.84
Roa5y	-11.26
ROCE	-56.4
ROE	-48.28
Roe5y	-17.94
ROIC	-277.7
Roic5y	-270.6

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	7.64%
Cagr3y	-26.82%
EPS Growth Years	0
Revenue Growth	-96.67x
Revenue Growth Q	-95.74x
Revenue Growth Years	0x
Revenue Growth3 Y	-38.98x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.01
Assets	$335.5M
Cash	$254.9M
Current Assets	$266.9M
Current Liabilities	$19.2M
Debt	$49.8M
Debt Equity	$0.18
Equity	$270.9M
Liabilities	$64.7M
Long Term Assets	$68.6M
Long Term Liabilities	$45.5M
Net Cash	$205.1M
Net Cash By Market Cap	$84.08
Net Cash Growth	-36.99%
Net Debt Equity	$-0.76
Tangible Book Value	$270.9M
Tangible Book Value Per Share	$7.52
WACC	2.32

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	13.9
Net Working Capital	$-2.9M
Quick ratio	13.4
Working Capital	$247.7M
Working Capital Turnover	$0.02

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-2.44%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	7.63%
200-day SMA	9.63
3Y total return	-60.82%
50-day SMA	6.75
50-day SMA vs 200-day SMA	50under200
All Time High	36.85
All Time High Change	-81.63%
All Time High Date	2021-11-18
All Time Low	4.93
All Time Low Change	37.32%
All Time Low Date	2025-08-11
ATR	0.53
Beta	-0.26
Beta1y	-0.29
Beta2y	1.17
Ch YTD	-34.14
High	7.04
High52	16.45
High52 Date	2026-05-06
High52ch	-58.84%
Low	6.45
Low52	4.93
Low52 Date	2025-08-11
Low52ch	37.32%
Ma50ch	0.24%
Premarket Change Percent	-9.16
Premarket Price	$5.95
Premarket Volume	208
Price vs 200-day SMA	-29.73%
RSI	50.32
RSI Monthly	39.87
RSI Weekly	41.99
Sharpe ratio	0.6x
Sortino ratio	0.79
Total Return	-2.44%
Tr YTD	-34.14
Tr1m	-12.19%
Tr1w	11.9%
Tr3m	-46.78%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	8
Analyst Count Top	4
Analyst Price Target Top	$17
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-1.07
Earnings Revenue Estimate	1,963,504x
Earnings Revenue Estimate Growth	0.69x
Operating Income	$-176.5M
Operating margin	-3,076.2
Price target	$18.75
Price Target Change	$177
Price Target Change Top	$151

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	21,412,907%
Float Percent	59.42%
Shares Insiders	1.76%
Shares Institutions	44.62%
Shares Out	36,033,548
Shares Qo Q	0.56%
Shares Yo Y	2.44%
Short Float	10.42%
Short Ratio	6.3
Short Shares	6.19

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-150.9M
Adjusted OCF	-150,966,000
Average Volume	448,546.3x
Bv Per Share	7.52
CAPEX	$59,000
Ch1m	-12.19
Ch1w	11.9
Ch1y	7.63
Ch3m	-46.78
Ch3y	-60.82
Ch6m	-41.94
Change	3.36%
Change From Open	3.36
Close	6.55
Days Gap	0
Depreciation Amortization	3,955,000
Dollar Volume	4,026,328.9
Earnings Date	2026-08-06
Earnings Time	bmo
EBIT	$-178.4M
EBITDA	$-174.5M
EPS	$-4
F Score	1
FCF	$-131.6M
FCF EV Yield	-338.95x
FCF Per Share	$-3.65
Financing CF	637,000
Fiscal Year End	December
Founded	2,016
Income Tax	$962,000
Investing CF	139,012,000
Ipr	-66.15
Iprfo	-74.45
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-02-26
Ma150	9.99
Ma150ch	-32.22%
Ma20	6.74
Ma20ch	0.52%
Net CF	7,949,000
Next Earnings Date	2026-08-10
Open	6.55
Optionable	Yes
Position In Range	54.24
Post Close	6.77
Postmarket Change Percent	-0.15
Postmarket Price	$6.76
Ppne	65,264,000
Pre Close	6.55
Price Date	2026-07-30
Ptbv Ratio	0.9
Relative Volume	1.33x
Revenue	5,738,000x
SBC By Revenue	335.76x
Share Based Comp	19,266,000
Tax By Revenue	16.77x
Tr6m	-41.94%
Us State	Massachusetts
Volume	594,731
Z Score	0.65

Entrada Therapeutics, Inc. (TRDA)

Coverage state: Market snapshot only — no published research

Generate the first TRDA analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · TRDA

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TRDA indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on TRDA

Frequently asked questions